Prof. Xiao Zhang, Shanxi Medical University, China
Dr. Xiao Zhang is a Professor in the Department of Pharmacy at Shanxi Medical University, specializing in drug/gene delivery and biomaterials. With a Ph.D. in Pharmaceutics from Sichuan University, his research focuses on designing smart nanoplatforms for tumor therapy and bone regeneration. Dr. Zhang has extensive experience in developing therapeutic biomaterials and multifunctional scaffolds. His innovative work has earned him numerous publications and patents. He has presented his work at major academic conferences, furthering the field of pharmaceutical nanotechnology. š§¬šš¦
Professional Profile:
Scopus
Summary of Suitability for Best Researcher Award
Dr. Xiao Zhang is exceptionally qualified for the Best Researcher Award due to his groundbreaking work in the fields of drug and gene delivery, biomaterials, and pharmaceutical nanotechnology. His career is marked by a unique combination of academic excellence, innovative research, and tangible contributions to the advancement of drug delivery systems and therapeutic biomaterials.
Education & Experience
- Ph.D. in Pharmaceutics, Sichuan University, 09/2013-06/2018 š
- B.E. in Pharmaceutical Engineering, University of Jinan, 09/2009-07/2013 š
- Professor, Shanxi Medical University, 07/2020-present š«
- Postdoctoral Researcher, University of California, Los Angeles, 10/2018-10/2019 š
- Research Focus: Nanotechnology in drug/gene delivery and biomaterials š§¬
Professional Development
Dr. Zhang has significantly contributed to the field of pharmaceutics with a focus on nanoplatforms for drug delivery and tumor therapy. His postdoctoral research at UCLA expanded his expertise in biomaterials, and he has since led multiple successful research projects as a principal investigator. Through academic conferences and collaborations, he has continually refined his knowledge of peptide-based dendrimers and smart nanomaterials for medical applications. His work stands at the intersection of pharmacy, materials science, and biotechnology, pushing the boundaries of therapeutic innovation. š¬š”š
Research Focus
Dr. Zhangās research focuses on the design and development of smart nanoplatforms for drug and gene delivery, aiming to enhance tumor therapy and bone regeneration. His work involves creating bioinspired peptide-based dendrimers, nanoparticles, and multifunctional scaffolds for osteogenesis and cancer treatment. He is dedicated to overcoming the challenges of drug-resistant tumors by engineering novel nanomaterials that improve therapeutic efficiency and bioavailability. His goal is to revolutionize how medicines are delivered within the body, using cutting-edge nanotechnology and biomaterials. ššš¦µ
Awards & Honors
- Patent: Nanoparticles for tumor-activated dual-penetration (Patent No. 201710853408.7) š
- Patent: Chiral dendritic peptide for autophagy induction (Patent No. 201710611754.4) š
- Patent: Tumor-specific dendrimeric prodrugs (Patent No. 201610999722.1) š
- Oral Presentation: “Tryptophan-Rich Peptide Dendrimers Mimicking Protein Drugs” at the 2015 China Materials Conference š
- Oral Presentation: 2015 China Biomaterials Conference š
Publication Top Notes:
-
Title: Complementary modulation of BMP signaling improves bone healing efficiency
-
Ā Title: Natural Chlorogenic Acid Planted Nanohybrids with Steerable Hyperthermia for Osteosarcoma Suppression and Bone Regeneration
-
Ā Title: Molecular and supramolecular engineering on lipopeptide-based hole-punching nanotoxins to trigger multimodal death of drug-resistant tumors: Apoptosis, necrosis and autophagy
-
Ā Title: Investigation of the internalization and transport mechanism of Codonopsis Radix polysaccharide both in mice and Caco-2 cells
-
Ā Title: Pharmacokinetics, distribution and excretion of inulin-type fructan CPA after oral or intravenous administration to mice